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To appear in: Phytomedicine
Received date: 4 January 2018
Revised date: 26 February 2018
Accepted date: 15 April 2018
Please cite this article as: Renata Marı́a Spina Zapata , Esteban Lozano , Patricia Andrea Barrera ,
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Background: Embelin (EMB), obtained from Oxalis erythrorhiza Gillies ex Hooker et 
Arnott (Oxalidaceae), was reported against Trypanosoma cruzi and Leishmania spp. 
Additionally, antiprotozoan activity against Plasmodium falciparum was reported for its 
methylated derivative (ME). Purpose: To evaluate the potential anti-Trypanosoma cruzi 
activity of EMB, ME and 2,5-di-O-methylembelin (DME) and analyze the possible 
mechanism of action. Study design/Methods: EMB was isolated by a chromatographic 
method from the air-dried ground whole plant. To evaluate the effects of methylation, 
ME and DME were synthesized and tested against T. cruzi epimastigotes and 
trypomastigotes. The most active compound ME was evaluated against amastigotes. 
Ultrastructural alterations, ROS generation and the effect on mitochondrial activity of 
ME were measured. Results: Compounds inhibited the proliferation of epimastigotes. 
ME was also active against intracellular amastigotes. Mitochondrial alterations were 
observed by TEM. Additionally, ME modified the mitochondrial activity, and induced an 
increase in ROS levels. These evidences postulate the mitochondrion as a possible target 
of ME. Conclusion: ME inhibited amastigotes proliferation, thus being a potential lead 
compound for the treatment of Chagas’ disease.  
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Chagas’ disease, which is endemic in Latin America, is a zoonotic parasitic disease 
caused by the protozoan parasite Trypanosoma cruzi. This illness affects 6 to 7 million 
people around the world (http://www.who.int/mediacentre/factsheets/fs340/es/). Over the 
last years, this disease has spread further.  In fact, the number of cases increased in 
countries receiving immigration from endemic areas.  In the United States, the CDC 
(Centers for Disease Control and Prevention) consider Chagas’ disease as 1 of the 5 
neglected parasitic infections in that country (Malik et al., 2015).  
Chagas’ disease comprises three phases: an acute phase, usually asymptomatic, a long 
silent period and finally some patients develop a chronic disease, in which the disease 
becomes evident with the appearance of cardiac dysfunction, and enlargement of some 
organs (colon and esophagus, 6-7%) (Bellini et al., 2010). Despite the intense efforts 
made to develop efficient antiparasitic drugs, an effective treatment for Chagas' disease 
is still lacking. Only nifurtimox and benznidazole are currently in use, albeit with 
restrictions due to the undesirable side effects and their low efficacy during the chronic 
phase. In addition, drug-resistant strains have been reported (Martínez et al., 2013). 
Consequently, new compounds against T. cruzi are needed. The plant kingdom is an 
important source of bioactive compounds, with many of them showing trypanocidal 
activity (Barros de Alencar et al,2017; Lozano et al., 2016). Additionally, chemical 
modifications of such compounds can improve their effect (Aponte et al., 2008).  
Palace-Berl et al. (2013) have reported that hydrophobic compounds are highly active 
against T. cruzi. It is known that certain molecules and processes are crucial for parasite 
survival, thus constituting ideal targets for drug action. Parasites have different defense 
against free radicals compared with mammalian cells; in this way this could be an 














that quinones are possible antitrypanocidal candidates due to their capacity to generate 
reactive oxygen species. Feresin et al., (2003) have demonstrated that the benzoquinone 
EMB isolated from Oxalis erythrorhiza causes 100% lysis of T. cruzi when employed at 
100 µg/ml. Additionally, EMB has many biological activities, such as anticancer, 
antiinflamatory, analgesic, antimitotic, antihelmithic, contraceptive, antispermatogenic, 
anticonvulsant and antidiabetic (Poojari, 2014). On the other hand, the antiprotozoal 
activity against Plasmodium falciparum, antitiviral and antitumor activities of 5-O-
methylembelin (ME) have been reported (Hussein et al., 2000; Narayanaswamy et al., 
2017; Xu et al, 2005). The aim of this work was evaluate the EMB, and its synthetic 
derivatives against T. cruzi.  
2. Materials and methods 
Chemicals, reagents and equipment 
All reagents and solvents used were of analytical grade. Petroleum ether (PE), 
Chloroform (CLF), dichloromethane (DCM), ethyl acetate (EtOAc), glutaraldehyde and 
diazomethane (CH2N2) were purchased from Aldrich Chemical Co. (St Louis, MO, 
USA). Methanol was purchased from J. T. Baker (Phillipsburg, NJ). Sephadex LH-20 
was purchased from Sigma -Aldrich Chemical Co. (St Louis, MO, USA). Thin layer 
chromatography (TLC) analysis was carried out on aluminum-coated silica gel (Aldrich) 
and cellulose F254 plates from Merck.  
For the structural identification of compounds, nuclear magnetic resonance (NMR) 
spectra were obtained with a Bruker Avance NMR spectrometer (Bruker Elektronik 
GmbH, Rheinstetten, Germany), operating at 400 MHz for 
1
H and 100 MHz for 
13
C. 
CDCl3 were used as solvents. Benznidazole (2-nitroimidazole), 3-(4,5 dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), and the probe 2',7'-














K2HPO4 (Merck- Darmstadt, Germany), tryptose (Oxoid Ltd., Hampshire, England), 
tryptone (ICN Biomedicals, Ohio USA), yeast extract (Merck- Darmstadt, Germany), 
hemin chloride (ICN Biomedicals, USA), bovine fetal serum (Internegocios, Argentina) 
and penicillin-streptomycin (Life technologies, USA) were used for the preparation of 
Diamond culture medium.  The following reagents were also employed: EUKITT 
mounting solution (O. Kindler GmbH & Co., Freiburg, Germany), DMEM (Gibco), 
Giemsa stain (Merck- Darmstadt, Germany), and resins (Spurr Low Viscosity Kit, Ted 
Pella). A Nikon eclipse 80i microscope, a Multiskan FC® Microplate Photometer 
(Thermo Scientific), a Fluoroskan Ascent FL, (Thermo scientific) and a Zeiss EM 900 
electron microscope were used. 
Plant material  
Oxalis erythrorhiza Gillies ex Hooker et Arnott (Oxalidaceae) whole plant specimens 
were collected during the blossoming period in the central Andes Region of Argentina, 
in December 2015. A voucher specimen was deposited at the herbarium of the Escuela 
de Química y Farmacia, Universidad de Chile, Santiago de Chile (no. SQF 21009). 
Extracts and isolation of embelin 
Extracts were obtained from the air-dried ground whole plant. A representative sample of 
the air-dried plant (1000 g) was successively extracted at room temperature with 
petroleum ether (PE), dichloromethane (DCM) and methanol (MeOH) to afford PE (30 
g; 3%), DCM (40 g; 4.00%) and MeOH (100 g; .10%) extracts. EMB was isolated from 
DCM extract as an orange solid (5g) (Feresin et al., 2003). 
Embelin derivatives 
EMB (1000 mg) was treated with CH2N2. The reaction mixture was stirred for 30 min at 
27 °C. After solvent removal under pressure, the solid was successively purified on a 














afford 350 mg of 5-O-methylembelin (2-hydroxy-5-methoxy-3-undecylcyclohexa-2,5-
diene-1,4-dione, 2,35% w/w yield), and 450 mg of 2,5-di-O- methylembelin (3,45% w/w 
yield). Spectroscopic data were in agreement with those previously reported (Joshi and 
Kamat, 1975; Gomez et al., 1989). 
Parasites and mammalian cells 
T. cruzi epimastigotes (Dm28c strain) were cultured at 28 °C in Diamond medium (0.1 
M NaCl, 0.05M K2HPO4, 0.625% tryptose, 0.625% tryptone, 0.625% yeast extract, pH 
7.2), supplemented with 10% inactivated fetal bovine serum (Gibco) and 12.5 µg/ml 
hemin (Lozano et al., 2012). Trypomastigotes and amastigotes were maintained in Vero 
cells (ATCC CCL-81) with DMEM supplemented with 10% fetal bovine serum at 37 °C 
in a 5% CO2 humidified incubator. Cell viability was determined by the MTT assay, 
according to Catunda et al.,2017. 
Proliferation and viability assays 
Epimastigotes (adjusted to 3 × 10
6
 cells/ml) were incubated at 28 °C with different 
concentrations (3.2 - 34 µM) of EMB, 2,5-di-O-methylembelin or 5-O-methylembelin in 
sterile tubes, and the volume was adjusted to 1 ml with Diamond medium. Controls 
without compounds, with DMSO (0.2%), and BZN (19.2 µM) were used in all 
experiments. Aliquots were collected every 24 h, and were fixed with 2% p-
formaldehyde in PBS. Parasites were counted in a Neubauer hemocytometer (Sülsen et 
al., 2010).  
Other aliquots from cultures were incubated for 5 min in 2% of eosin in PBS, pH 7.2 and 
were analyzed under light microscopy. The percentage of dead parasites (stained cells) 
was determined in every treatment (Lozano et al., 2012). 
To evaluate the effect of compounds on the viability of infective forms, trypomastigotes 














DMEM with different concentrations of ME (37 °C - 24 h). Subsequently, aliquots were 
stained with eosin, as previous detailed. 
Ultrastructural analysis by transmission electron microscopy 
The ultrastructural study was carried out according to Brengio et al. (2000). Briefly, 
treated or non-treated parasites were collected, centrifuged at 3000 rpm, and fixed with 
2% glutaraldehyde in PBS (24 h at 4 ºC). Cells were washed twice with PBS, and then 
incubated overnight with 1% osmium tetroxide at 4 ºC. Parasites were washed twice and 
dehydrated  with increasing concentrations of acetone, and pre-infiltrated in a 1:1 
solution of acetone and Spurr Low Viscosity Kit, Ted Pella resin for 2 h. Cells were then 
centrifuged and embedded in pure Spurr Low Viscosity Kit, Ted Pella resin for 24 h at 
60 ºC. Ultrathin sections were cut with a Power Tone XL ultramicrotome and contrast-
stained with uranyl acetate and lead citrate. Samples were analyzed in an EM 900 Zeiss 
electron microscope. 
Mitochondrial activity 
Epimastigotes (Dm28c strain, 3 × 10
6
/ml), were treated with 30 µM ME for 24 h. 
Parasites were then centrifuged at 3000 rpm for 10 min. The parasites-containing pellet 
was resuspended in 100 µl of Diamond medium and 10 µl MTT (5 mg/ml) with 
phenazine methosulfate (0.22 mg/ml) in PBS and incubated for 4 h at 28 °C. The 
suspension was then centrifuged, and the medium removed. The precipitate was 
dissolved with 100 µl DMSO and the absorbance was measured at 570 nm using a FC® 
Microplate Photometer, Thermo Scientific (Ormeño et al., 2016). 
ROS generation 
Epimastigotes (5 x 10
6
) were incubated in Diamond medium with or without 30 µM ME 
for 24 and 48 h. Parasites were then incubated with 10 µM of H2CDFA for 1 h at 28 °C 














suspended in PBS. The fluorescence intensity was detected in a fluorimetric microplate 
reader Fluoroskan Ascent FL, (Thermo scientific) with excitation and emission 
wavelengths of 485 and 538 nm, respectively (Barrera et al., 2013).  
Compound activity against intracellular amastigotes 
Vero cells were grown in T25 flasks in DMEM (supplemented with 10% FBS), and then 
infected with trypomastigotes at a parasite:cell ratio of 10:1 for 2 days. Subsequently, 2 x 
10
4 
cells were subcultured in 24 multiwell plates containing sterile coverslips. After 6 h, 
19.2 µM BZN or 16 µM 5-O-methylembelin in DMSO were added and incubated for 24 
h at 37 ºC. Controls were performed with 0.2% DMSO. After incubation, Vero cells 
were washed and processed for light microscopy. Three independent experiments were 
performed in triplicate. The coverslips containing the infected cells were washed once 
with PBS and cells were fixed for 1 min with pure methanol, and stained with 10% 
Giemsa in water for 20 min. After discarding the excess of dye, the cells were washed 
three times with distilled water and the coverslips were mounted on slides with EUKITT 
mounting solution. Cells were observed under a light  microscope and the percentage of 
infected cells, as well as the number of parasites per cell were determined from 200 Vero 
cells counted per experiment (from fields taken at random). For each condition (control, 
BZN and ME treatment) infected cells were classified according to the number of 
intracellular amastigotes as: group I (1 to 10 parasites per cell), group II (11 to 20 
parasites per cell) and group III (more than 20 parasites per cell). Results were expressed 
as the percentage of infected cells in each category. For each condition the summation of 
infected cells was considered 100%. 
Release of trypomastigotes to the culture medium 
Treated (16 µM ME) or non-treated infected Vero cells were incubated for 24 h in 














one. Cells were incubated for other 48 h at 37 °C. Aliquots of culture medium were 
collected every 24 h and counted in a Neubauer hemocytometer as described previously 
(Lozano et al, 2012). 
Infectivity of released trypomastigotes 
The trypomastigotes obtained from the culture medium of infected cells under the 
conditions described above were centrifuged, washed once with PBS and resuspended in 
fresh medium. These parasites were then added to growing Vero cells on slides at a 
parasite:cell ratio of 10:1. After 24 h of incubation, slides were stained with Giemsa to 
evaluate cell infection. 
Pre-treatement of Vero cells with 5-O-methylembelin 
To evaluate the sensitivity of ME pre-treated cells to infection, 2 x 10
4 
cells were 
cultured in 24 multiwell plates containing sterile coverslips in the absence (control) or in 
the presence of 16 µM ME for 24 h. Vero cells were then washed with PBS, and fresh 
medium was added together with parasites at a parasite:cell ratio of 10:1. Cells were 
incubated for 24 h. Subsequently, the slides were fixed with methanol and stained with 
Giemsa to estimate the infection index (as percentage of infected cells). 
Statistical analysis 
The Student’s t test was used to determine the statistical significance of the difference 
between treated and control groups. The effect of each treatment was analyzed by one-
way analysis of variance (ANOVA). 
3. Results  
EMB, which is recommended for hepatic and heart disorders, causes lysis of T. cruzi. 
Based on this, a possible link between the traditional use and the trypanocidal effect was 
suggested (Feresin et al., 2003). In this work, the efficacy of embelin (EMB), and 5-O-














tested on T. cruzi. The chemical structures of EMB and its derivatives are shown in Fig. 
1. 
Insert Fig. 1 
 As observed in the Table 1, EMB and its derivatives inhibit epimastigote proliferation. 
The inhibitory effect observed on the proliferation of T. cruzi epimastigotes was stronger 
for ME than for EMB and DME (Table 1).  
Insert Table1 
However, no significant differences were detected for neither EMB (34 µM) nor ME (16 
µM), as compared to the reference drug BZN (19.2 µM) at all the timepoints tested. 
Moreover, the effect of ME on epimastigote proliferation was dose-dependent. On the 
first day of treatment, no significant differences were detected between the effect caused 
by the compounds and that of BZN. At 48 h of treatment, and for all concentrations 
evaluated, ME caused a significant inhibition on parasite growth, as compared to the 
control group. This inhibition was more marked at 72 h of incubation (p < 0.001).  In 
fact, the IC50 values for ME and BZN were similar (21 ± 0.69 µM vs. 19.2 ± 1.4 µM, 
respectively).  
As shown in the Table 2, both compounds (EMB and ME) exerted a cytostatic rather 
than a cytotoxic effect, since mortality did not exceed 2.4 ± 0.54% at 24 - 72 h of 
treatment at all the concentrations used. The activity of ME was also evaluated on the 
infective forms, showing a mild deleterious effect on trypomastigotes (12.29 ± 5.99% 
mortality, Table 2).    














Additionally, the cytotoxicity of ME was assessed on Vero cells. No significant 
differences were observed at 24 h of treatment between 16 µM of ME and BNZ (data not 
shown).  
Transmission electron microscopy (TEM) is an important tool to investigate the 
mechanism of action of trypanocidal drugs (Soeiro et al., 2011). Thus, this methodology 
was employed to assess the effect of ME on T. cruzi.  Results showed that ME induces 
some ultrastructural alterations on epimastigotes. After 24 h of treatment with 30 µM 
ME, most of the parasites exhibited a cytoplasmic disorganization, mitochondrial 
swelling, and a kinetoplast deformity (Fig. 2B).  
Insert Fig. 2 
At 48 h of treatment, a moderate vacuolization was also observed in most of the 
parasites, with some of them containing electrodense material inside (Fig. 2D). The 
integrity of the plasma membrane was preserved, although some membrane blebs 
appeared at 48 h of treatment (Fig. 2D).  
The fact that kinetoplastids have a single branched mitochondrion with a DNA structure 
named kinetoplast, which is not present in mammalian cells, makes this organelle an 
attractive drug target.  The mitochondrial swelling and kinetoplast disruption caused by 
ME was also evaluated in terms of mitochondrial activity by the MTT assay. Fig. 3 
shows that after of 24 h of treatment with ME, the mitochondrial activity was reduced  
by 21.66 ± 3.62%, as compared to untreated parasites (p < 0.05). However, at 48 h of 
treatment, the mitochondrial activity was increased by 37.81 ± 9.94% compared to the 
controls. This unexpected effect could indicate the existence of a parasite population that 
is less sensitive to the drug, or with higher mitochondrial activity.  














The particular defense mechanism against free radicals existing in trypanosomatids 
makes them particularly sensitive to oxidative stress (Jimenez et al., 2014). Thus, 
parasites are vulnerable to compounds with oxidative activity, such as those containing 
quinone groups (e.g. ME) (Soeiro et al., 2011). Considering the changes in mitochondrial 
activity induced by ME, the ROS production was measured using the fluorescence probe 
H2CDFA. As shown in the Fig. 4, the ROS generation increased significantly (p < 0.05) 
after 24 h of treatment with ME. Although this trend was maintained at 48 h of 
treatment, no significant differences were detected at this timepoint, as compared to 
controls. 
Insert Fig. 4 
T. cruzi amastigotes (intracellular stage) are crucial for the development of Chagas' 
disease, and to complete its life cycle. Literature data on the activity of compounds 
against amastigotes are scarce (Muschietti et al, 2013). In our work, ME was found to be 
active against the intracellular forms of the parasite and non-toxic to the host cells. 
Although ME did not cause a significant change as regards the percentage of infected 
cells (Fig. 5A), the number of intracellular parasites decreased (Fig. 5B).  
Insert Fig. 5 
Insert Fig. 6 
This effect was evident as early as 24 h of incubation with ME. Thus, only 2.37 ± 0.51% 
of infected and treated cells contained more than 20 amastigotes, while the percentage of 
infected and non-treated cells containing more than 20 amastigotes was 13.87 ± 1.14%. 
The effect caused by ME was similar to that of BZN (Fig. 6). 
After several cycles of cell division in the host cell cytoplasm, amastigotes transform 














As observed in Fig. 7, the number of parasites released (obtained from culture 
supernatant) was significantly lower than that of control cultures 2 and 3 days after start 
of treatment with ME,  (p < 0.001).  
Insert Fig. 7 
Finally, the infectivity of parasites released from ME-treated cells was evaluated. After 
collecting parasites from the culture medium from either control or treated cells, they 
were incubated with growing Vero cells for 24 h. Neither the percentage of infected cells 
nor the number of parasites per cell was different for parasites obtained from controls or 
from ME- treated cells, indicating that the compound did not alter the infectivity (data 
not shown).  
The activity against intracellular amastigotes reflects the ability of ME to cross the 
plasma membrane. In this sense, Lu et al., (2013) have reported that EMB is a 
component of a nanomicellar carrier. In order to evaluate if the pretreatment of cells with 
ME affects the infection rate, cells were preincubated with this compound (16 µM) for 
24 h. The medium was then removed and the culture was incubated with the parasites for 
24 h in fresh medium. Results showed that ME-pretreated cells did not differ 
significantly from controls in neither the number of infected cells nor in the replication 
















American trypanosomiasis (Chagas’ disease) is among the most important parasitic 
infections belonging to the group of neglected tropical diseases. The few therapeutic 
alternatives available for the treatment of this disease and their side effects that these 
drugs cause on patients, has prompted the search for new active molecules against T. 
cruzi. In this sense, the plant kingdom offers an extensive source of compounds (Barros 
de Alencar et al, 2017; Gallucci et al., 2014). In addition, some molecules obtained from 
plant materials can be chemically modified to improve the activity (Aponte et al., 2008). 
Among them, several biological activities of the benzoquinone embelin (EMB) have 
been reported (Feresin et al., 2003; Poojari, 2014). Two methylated derivative 
compounds were synthesized from embelin which showed that methylation improves the 
bioactivity, as occurs with other molecules (Salomoa et al., 2013). It is likely that the 
incorporation of a methyl group conferred embelin a higher degree of lipophilicity, 
which favored its entrance into the parasite cell (Palace –Berl et al., 2013). However, the 
dimethylated derivative (DME) was less active than the monomethylated one (ME) (IC50 
7.07 ± 0.23 µM), which suggests that the free hydroxyl group in position 2 influences the 
activity of embelin derivatives. Therefore, it is likely that the active group be the 
carbonyl moiety present in C1. Both, EMB and ME, presented cytostatic activity on 
parasites at the concentrations evaluated. However ME at higher concentrations could 
have toxic effects as embelin (Feresin et al., 2003). The fact that ME has cytostatic rather 
than cytotoxic activity suggests that the drug could interfere with critical steps of the 
parasite’s cell cycle. 
ME induced ultrastructural alterations on epimastigotes, such as kinetoplast 
disorganization and mitochondrial swelling. Similar effects on the mitochondrion have 
been reported for naftoquinones (Salomao et al, 2013) and other compounds. These 














membrane proteins or enzymes (Izumi et al., 2007). Other authors have demonstrated 
that quinones inhibit redox enzymes and components of the respiratory chain 
(Sepulveda-Boza et al., 1996). In fact, EMB is considered a weak mitochondrial 
uncoupler agent, producing cell death in proliferating endothelial cells (Coutelle et al. 
2014). Furthermore, the mitochondrial swelling has also been attributed to alterations in 
the ergosterol metabolism (Kessler et al 2013).  
Membrane blebs were also observed after treatment with ME. Some authors have 
reported these blebs as normal structures in other trypanosomatids (Diniz Atayde et al., 
2015), whereas other studies suggest that such structures are produced by quinones and 
other compounds that affect the proliferation of amastigotes and epimastigotes (Sthal-
Vieira, 2011). The ROS generation has been associated with these alterations by 
oxidation of lipid rafts on the plasmalemma (Oliveira dos Anjos et al. 2016).  
ME also induced deformities in the kinetoplast, suggesting that the compound would 
exert additional effects. It is known that the kinetoplast is made of a special type of DNA 
(k-DNA) which is located in a specialized portion of the mitochondrion. Evidences have 
confirmed the presence of basic proteins (H1 histone-like) in the kinetoplast that could 
participate in the condensation of k-DNA in T. cruzi (Cavalcanti et al., 2004). ME would 
then interrupt such condensation. 
The mitochondrial alteration was also confirmed biochemically by the MTT assay (Fig. 
3). The reduction of MTT is mainly carried out by mitochondrial dehydrogenases, thus, 
the reduced levels of MTT formazan observed after 24 h of treatment with ME support 
the alterations observed by TEM. Conversely, the increased mitochondrial activity 
observed at 48 h could be explained as the development of a parasite selection process 
that would be less sensitive to the uncoupling effects of ME. However, it should be borne 














quinones, which is attributed to their structural properties (Salomao et al., 2013). This 
process could be initiated by the loss of one or two electrons, generating a semiquinone 
or a hydroquinone, respectively.  These unstable molecules can produce free radicals 
(Soeiro et al., 2011). In this case, the population of parasites selected at 48 h could have a 
more efficient ROS detoxification system. On the other hand, it is important to remark 
that compounds like triazoles, that inhibit the sterol biosynthesis, produce accumulation 
of 14-α-methylsterol, which is toxic for systems like the electron transport chain. This 
effect could also explain the decrease in mitochondrial activity and the ROS generation 
(Maya et al., 2007). 
In this study, we also observed that the proliferation of intracellular amastigotes was 
affected by ME, similarly to BZN. The latter effect constitutes a relevant finding, since 
currently, there are no drugs that are active on the intracellular form of T. cruzi.   When 
the parasites invade cells, they are initially confined to a parasitophorous vacuole, from 
where they escape into the cytosol to transform into the proliferative amastigote form. 
After several rounds of replication in the form of amastigote, parasites differentiate into 
trypomastigotes, which are then released to the extracellular medium to infect new cells 
(Burleigh et al., 2002). Our results showed that the treatment with ME significantly 
reduced the number of extracellular parasites (trypomastigotes), presumably as a result 
of a decrease in the number of amastigotes. However, ME might also affect either the 
differentiation into trypomastigotes or the release of parasites from the infected cells. 
Interestingly, the infectivity of parasites released from ME-treated cells was preserved, 
since they were able to invade new cells, similarly to control non-treated parasites.  
In this study, it was demonstrated that the methylation of embelin potentiates its action 
against T. cruzi, presumably by facilitating its entrance into the parasites. The drug was 














intracellular developing steps of the parasites as well as the targeting of other parasite 
processes cannot be ruled out.  
5. Conclusions 
Our work demonstrates that EMB and its derivatives are active compounds against T. 
cruzi epimastigotes. Amastigotes were also sensitive to ME. Since EMB is a potential 
drug against multiple diseases, further studies should be carried out in other biological 
models. Finally, it can be concluded that ME, the EMB methylated derivative, could be a 
useful hit for the development of semisynthetic drugs active against T. cruzi. Its capacity 
to reduce the amastigote load would render it a special candidate for the treatment of 
chronic Chagas’ disease. 
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Table 1. Proliferation of epimastigotes (Dm28c strain) incubated in the absence (control) 
or the presence of either EMB, ME, DME or BZN (positive control). Values are 
expressed as percentages of proliferation (means ± SEM) after 24, 48 or 72 h of 
incubation. (*) (**)(***) Significantly different from the control (p < 0.05; p < 0.01; p > 
0.001, respectively). 
Table 2. Cytotoxicity of compounds on epimastigotes and trypomastigotes was 
evaluated by the eosin exclusion method. Values are expressed as percentages of dead 
cells (means ± SD) after 24, 48 or 72 h of incubation. (*) Significantly different from the 
control, (p < 0.05). Results were determined in triplicate. 
 
Figure legends 
Fig. 1. Chemical structure of embelin and its derivatives 
Fig. 2.  Ultrastructure of the epimastigotes observed by transmission electron microscopy 
(TEM) after incubation for 24 or 48 h in the absence (A and C) or in the presence of ME 
(B and D).White asterisks: nucleus; white arrowhead: kinetoplast; white arrow: vacuole; 
black arrow: mitochondrion, black arrowhead: flagellum. 
Fig. 3. Mitochondrial activity of epimastigotes. Parasites were treated with 30 µM ME 
for 24 and 48 h. Results are expressed as mean ± SEM (n = 3). (*) Significantly different 














Fig. 4. ROS generation on epimastigotes after 24 and 48 h treatment with 30 µM ME. 
Results are expressed as mean ± SEM (n = 5). (**), significant differences, as compared 
to control (p < 0.05). 
Fig. 5. Infected Vero cells treated with 16 µM ME for 24 h (A and B). After incubation, 
the percentage of infected Vero cells (A), and the number of amastigotes per cell (B), 
were estimated. (*) and (***), significantly different from the control (p < 0.05 and p < 
0.001, respectively). Results are expressed as mean ± SEM (n = 3). 
Fig. 6. Giemsa stained microscopic images of Vero cells. (A): uninfected, (B): infected 
and untreated, (C): infected and treated (16 µM ME for 24 h) Vero cells. Arrows indicate 
intracellular amastigotes. 
Fig. 7. Parasites released into the culture medium at the indicated time-points after the 
treatment with 16 µM ME for 24 h. Results are expressed as mean ± SEM (n=3). (**), 






















































































































































30 (µM) 16 (µM) 8 (µM) 3.2 (µM) 34 
24 h 1.8 ± 1.48 1.8 ± 1.09 2.4 ± 0.54 1.8 ± 1.3 1.4 ± 1.4 1.8 ± 1.09 
48 h 1.4 ± 0.89 1.2 ± 0.84 1.2 ± .09 1.6 ± 1.52 1.2 ± 1.15 1.2 ± 0.84 
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